| 000 | 01604 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515063006.0 | ||
| 264 | 0 | _c20070502 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/01.wnl.0000258660.74391.c1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPahwa, R | |
| 245 | 0 | 0 |
_aRopinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. _h[electronic resource] |
| 260 |
_bNeurology _cApr 2007 |
||
| 300 |
_a1108-15 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase III; Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 | _aInternational Cooperation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aStacy, M A | |
| 700 | 1 | _aFactor, S A | |
| 700 | 1 | _aLyons, K E | |
| 700 | 1 | _aStocchi, F | |
| 700 | 1 | _aHersh, B P | |
| 700 | 1 | _aElmer, L W | |
| 700 | 1 | _aTruong, D D | |
| 700 | 1 | _aEarl, N L | |
| 773 | 0 |
_tNeurology _gvol. 68 _gno. 14 _gp. 1108-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/01.wnl.0000258660.74391.c1 _zAvailable from publisher's website |
| 999 |
_c16956465 _d16956465 |
||